Breaking News Instant updates and real-time market news.

2020-02-04 06:47:28 ARMK Aramark $43.85 / -0.28 (-0.63%) 06:47 02/04/20 02/04 06:47 02/04/20 06:47	Aramark says 'activating strategies to accelerate future revenue growth' The company is currently activating strategies to accelerate future revenue growth and unlock the economic potential of the business. These actions include fostering a hospitality culture, aligning leadership and operational resources, as well as initiating targeted investments that will support new account sales efforts and client retention; enhanced product and service offerings; and value-added innovation and technology-all executed with a commitment to drive long-term shareholder value. "Since joining Aramark a few weeks ago, I have spent time immersing myself in the organization and have already confirmed my initial belief in the growth potential for the business," said Tom Ondrof, Aramark's CFO. "While appreciating the immediate work ahead of us, I am confident that we will execute over time on our actions and position Aramark for sustained excellence. As these strategies are implemented, the Company maintains its near-term financial performance outlook for Fiscal 2020."	04 Feb
ARMK Aramark $43.85 / -0.28 (-0.63%) 01/17/20 Berenberg Aramark downgraded to Hold from Buy at Berenberg 01/17/20 Berenberg Aramark downgraded to Hold from Buy at Berenberg 11/21/19 Jefferies Jefferies initiates Diversifed Services sector 11/21/19 Jefferies Aramark initiated with a Hold at Jefferies

2020-02-04 06:47:28

ARMK

Aramark

$43.85 / -0.28 (-0.63%)

06:47

02/04/20

02/04

06:47

02/04/20

06:47

Aramark says 'activating strategies to accelerate future revenue growth'

The company is currently activating strategies to accelerate future revenue growth and unlock the economic potential of the business. These actions include fostering a hospitality culture, aligning leadership and operational resources, as well as initiating targeted investments that will support new account sales efforts and client retention; enhanced product and service offerings; and value-added innovation and technology-all executed with a commitment to drive long-term shareholder value. "Since joining Aramark a few weeks ago, I have spent time immersing myself in the organization and have already confirmed my initial belief in the growth potential for the business," said Tom Ondrof, Aramark's CFO. "While appreciating the immediate work ahead of us, I am confident that we will execute over time on our actions and position Aramark for sustained excellence. As these strategies are implemented, the Company maintains its near-term financial performance outlook for Fiscal 2020."

04
Feb

ARMK Aramark

$43.85 / -0.28 (-0.63%)

01/17/20 Berenberg: Aramark downgraded to Hold from Buy at Berenberg

01/17/20 Berenberg: Aramark downgraded to Hold from Buy at Berenberg

11/21/19 Jefferies: Jefferies initiates Diversifed Services sector

11/21/19 Jefferies: Aramark initiated with a Hold at Jefferies

TODAY'S FREE FLY STORIES

Periodicals	Land & Buildings wants committee to oversee Monmouth review, Bloomberg reports » 10:53 01/26/21 01/26 10:53 01/26/21 10:53 MNR Monmouth Real Estate $17.55 / +0.02 (+0.11%) Jonathan Litt's Land… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events MNR Monmouth Real Estate $17.55 / +0.02 (+0.11%) 01/15/21 Blackwells intends to nominate four director candidates to Monmouth board 01/14/21 Monmouth Real Estate to explore strategic alternatives 01/14/21 Monmouth Real Estate raises quarterly dividend 5.9% to 18c per share 12/21/20 Monmouth Real Estate confirms $18.00 per share offer from Blackwells Capital MNR Monmouth Real Estate $17.55 / +0.02 (+0.11%) 01/15/21 BMO Capital BMO raises Monmouth Real Estate price target to $18 after review announcement 12/22/20 B. Riley Securities Monmouth Real Estate price target raised to $20 from $18 at B. Riley 10/28/20 Berenberg Monmouth Real Estate initiated with a Buy at Berenberg 10/26/20 National Securities Monmouth Real Estate initiated with a Buy at National Securities MNR Monmouth Real Estate $17.55 / +0.02 (+0.11%) 11/23/20 Monmouth Real Estate reports Q4 AFFO 19c, consensus 21c 08/04/20 Monmouth Real Estate reports Q3 FFO 20c, consensus 21c MNR Monmouth Real Estate $17.55 / +0.02 (+0.11%) 12/21/20 Blackwells offers to buy rest of Monmouth for $18 per share, Bloomberg says MNR Monmouth Real Estate $17.55 / +0.02 (+0.11%) 12/21/20 Fly Intel: Pre-market Movers 02/04/21 Monmouth Real Estate - MNR
Conference/Events	LiqTech to host virtual investor day » 10:50 01/26/21 01/26 10:50 01/26/21 10:50 LIQT LiqTech $8.42 / +0.82 (+10.79%) Virtual Investor Day to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events LIQT LiqTech $8.42 / +0.82 (+10.79%) 08/10/20 LiqTech reports Q2 EPS (12c), consensus (4c) LIQT LiqTech $8.42 / +0.82 (+10.79%) 10/15/20 Stephens LiqTech resumed with an Equal Weight at Stephens 10/02/20 B. Riley Securities LiqTech price target raised to $11 from $8 at B. Riley Securities LIQT LiqTech $8.42 / +0.82 (+10.79%) 07:04 Today LiqTech sees Q4 revenue $4.1M, consensus $4.58M 11/09/20 LiqTech reports Q3 EPS (18c), consensus (7c) 03/15/21 33rd Annual Roth Virtual Conference 08:00 Today LiqTech International, Inc.
Downgrade	Cleveland-Cliffs downgraded to Hold on 'emerging headwinds' at GLJ Research » 10:49 01/26/21 01/26 10:49 01/26/21 10:49 CLF Cleveland-Cliffs $16.25 / -0.335 (-2.02%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CLF Cleveland-Cliffs $16.25 / -0.335 (-2.02%) 12/09/20 ArcelorMittal completes sale of ArcelorMittal USA to Cleveland-Cliffs 11/25/20 Cleveland-Cliffs receives antitrust clearance for ArcelorMittal USA acquisition 10/23/20 Cleveland-Cliffs still expects to be free cash flow positive in 2H 10/23/20 Cleveland-Cliffs expects to close acquisition of ArcelorMittal USA by year-end CLF Cleveland-Cliffs $16.25 / -0.335 (-2.02%) 09:09 Today GLJ Research Cleveland-Cliffs downgraded to Hold on 'emerging headwinds' at GLJ Research 08:47 Today GLJ Research Cleveland-Cliffs downgraded to Hold from Buy at GLJ Research 01/18/21 Exane BNP Paribas Cleveland-Cliffs upgraded to Outperform from Neutral at Exane BNP Paribas 01/12/21 B. Riley Securities Cleveland-Cliffs price target raised to $20 from $16 at B. Riley Securities CLF Cleveland-Cliffs $16.25 / -0.335 (-2.02%) 01/25/21 Cleveland-Cliffs sees Q4 revenues $2.2B-$2.4B, consensus $1.82B 10/23/20 Cleveland-Cliffs reports Q3 EPS (2c), consensus (10c) 09/28/20 Cleveland-Cliffs expects ArcelorMittal USA acquisition to be EPS accretive 07/30/20 Cleveland-Cliffs reports Q2 EPS (31c), consensus (50c) CLF Cleveland-Cliffs $16.25 / -0.335 (-2.02%) 08/27/20 Nucor, US Steel raise sheet prices by $40/st, Argus says CLF Cleveland-Cliffs $16.25 / -0.335 (-2.02%) 09/28/20 Fly Intel: Wall Street's top stories for Monday 09/28/20 Fly Intel: Wall Street's top stories at midday 09/28/20 Fly Intel: Pre-market Movers 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference 02/25/21 Cleveland-Cliffs - CLF 05/11/21 Cleveland-Cliffs CLF Cleveland-Cliffs $16.25 / -0.335 (-2.02%) 01/15/21 Cleveland-Cliffs call volume above normal and directionally bullish 01/05/21 Cleveland-Cliffs call volume above normal and directionally bullish 12/28/20 Cleveland-Cliffs put volume heavy and directionally bearish 12/09/20 Cleveland-Cliffs call volume above normal and directionally bullish
Hot Stocks	RegeneRx addresses rumors regarding ARISE-3 phase 3 dry eye trial 10:48 01/26/21 01/26 10:48 01/26/21 10:48 RGRX RegeneRx $0.00 / + (+0.00%) ShowHide Related Items >><< Company News RGRX RegeneRx $0.00 / + (+0.00%) 10:48 Today RegeneRx: ARISE-3 patient database 'continuing to be cleaned' 10/14/20 RegeneRx expects to complete enrollment for ARISE-3 Phase 3 trial in November 08/19/20 RegeneRx: Enrollment in Phase 3 ARISE-3 trial reaches 600 patients
Hot Stocks	RegeneRx: ARISE-3 patient database 'continuing to be cleaned' » 10:48 01/26/21 01/26 10:48 01/26/21 10:48 RGRX RegeneRx $0.00 / + (+0.00%) RegeneRx… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News RGRX RegeneRx $0.00 / + (+0.00%) 10/14/20 RegeneRx expects to complete enrollment for ARISE-3 Phase 3 trial in November 08/19/20 RegeneRx: Enrollment in Phase 3 ARISE-3 trial reaches 600 patients

Conference/Events	Earthstone Energy management to meet virtually with Roth Capital » 10:47 01/26/21 01/26 10:47 01/26/21 10:47 ESTE Earthstone Energy $5.65 / +0.07 (+1.25%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ESTE Earthstone Energy $5.65 / +0.07 (+1.25%) 12/18/20 Earthstone Energy rises 14.8% 12/18/20 Earthstone Energy to acquire IRM for $185.9M in cash, shares 11/04/20 Earthstone Energy sees FY20 CapEx $65M-$70M 08/05/20 Earthstone Energy expects to average 13,000 - 14,000 Boepd for full year ESTE Earthstone Energy $5.65 / +0.07 (+1.25%) 01/04/21 Northland Earthstone Energy named a Top Pick for 2021 at Northland 12/16/20 Wells Fargo Wells Fargo says Buy Marathon Oil, Sell Berry Petroleum 12/16/20 Wells Fargo Earthstone Energy upgraded to Overweight from Equal Weight at Wells Fargo 09/02/20 Alliance Global Partners Earthstone Energy assumed with a Buy at Alliance Global Partners ESTE Earthstone Energy $5.65 / +0.07 (+1.25%) 11/04/20 Earthstone Energy reports Q3 adjusted EPS (18c), consensus 8c 08/05/20 Earthstone Energy reports Q2 adjusted EPS 20c, consensus 10c 03/15/21 33rd Annual Roth Virtual Conference 00:00 Today Earthstone Energy 01/27/21 Earthstone Energy
Conference/Events	Akebia management to meet virtually with Mizuho » 10:46 01/26/21 01/26 10:46 01/26/21 10:46 AKBA Akebia $3.73 / +0.02 (+0.54%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options AKBA Akebia $3.73 / +0.02 (+0.54%) 11/16/20 Akebia reports manuscript on global Phase 3 INNO2VATE program rationale 10/23/20 Akebia down 1% to $3.24 after reporting additional data on vadadustat 10/23/20 Akebia trading resumes 10/23/20 Akebia CEO confident vadadustat has 'straightforward path to potential approval' AKBA Akebia $3.73 / +0.02 (+0.54%) 10/23/20 Piper Sandler Akebia rally justified as vadadustat has chance, says Piper Sandler 10/23/20 JPMorgan JPMorgan says Akebia's data 'do little' to restore confidence in NDD approval 09/04/20 RBC Capital Akebia price target lowered to $5 from $12 at RBC Capital 09/04/20 Stifel FibroGen's roxadustat can be 'dominant leader' as competitor fades, says Stifel AKBA Akebia $3.73 / +0.02 (+0.54%) 11/05/20 Akebia reports Q3 EPS (42c), consensus (17c) 08/10/20 Akebia reports Q2 EPS ($1.28), consensus (50c) 12 May AKBA Akebia $3.73 / +0.02 (+0.54%) 01/13/21 Researchers awarded funding to expand Akebia drug trial, UTHealth News says AKBA Akebia $3.73 / +0.02 (+0.54%) 09/03/20 Fly Intel: Wall Street's top stories for Thursday 09/03/20 Fly Intel: Wall Street's top stories at midday 09/03/20 Fly Intel: Pre-market Movers 08/10/20 Fly Intel: After-Hours Movers 00:00 Today Akebia 01/27/21 Arcus Biosciences AKBA Akebia $3.73 / +0.02 (+0.54%) 10/12/20 Unusually active option classes on open October 12th
General news	The January bounce in the U.S. consumer confidence index » 10:45 01/26/21 01/26 10:45 01/26/21 10:45 The January bounce in the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Options	Twitter call volume above normal and directionally bullish » 10:45 01/26/21 01/26 10:45 01/26/21 10:45 TWTR Twitter $50.35 / +2.5 (+5.22%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TWTR Twitter $50.35 / +2.5 (+5.22%) 10:39 Today Twitter acquires newsletter company Revue 01/25/21 Twitter announces proposed settlement of shareholder derivative lawsuits 01/25/21 Twitter introduces Birdwatch community-based approach to misinformation 01/13/21 Twitter CEO says @realDonaldTrump ban 'right decision' for company TWTR Twitter $50.35 / +2.5 (+5.22%) 01/20/21 Piper Sandler Twitter initiated with a Neutral at Piper Sandler 01/19/21 KeyBanc Facebook price target raised to $345 from $340 at KeyBanc 01/13/21 Fly Intel: Top five analyst upgrades 01/13/21 MKM Partners Twitter upgraded to Buy from Neutral at MKM Partners TWTR Twitter $50.35 / +2.5 (+5.22%) 10/29/20 Twitter reports Q3 adjusted EPS 19c, consensus 6c 10/29/20 Notable companies reporting after market close TWTR Twitter $50.35 / +2.5 (+5.22%) 06:06 Today Twitter bans MyPillow CEO on 'repeated violations' of policy, NY Times reports 01/21/21 China state media seeing less 'likes,' or 'retweets,' on Twitter, Newsweek says 01/20/21 Facebook rival MeWe adds 2.5M privacy-seeking users in a week, USA Today says 01/10/21 Airbnb Section 230 use underscores law's reach beyond Facebook, WSJ says TWTR Twitter $50.35 / +2.5 (+5.22%) 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler 01/13/21 Tesla initiation, Home Depot upgrade among today's top calls on Wall Street 02/11/21 Technology & Internet Virtual Conference 02/09/21 Twitter - TWTR 02/25/21 Twitter, Inc. TWTR Twitter $50.35 / +2.5 (+5.22%) 01/20/21 Unusually active option classes on open January 20th 01/12/21 Notable open interest changes for January 12th 12/14/20 Twitter call volume above normal and directionally bullish 12/11/20 Notable open interest changes for December 11th
General news	FX Action: USD-CAD » 10:45 01/26/21 01/26 10:45 01/26/21 10:45 FX Action: USD-CAD traded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

General news	8-Week Bill Announcement to be released at 11:00 10:45 01/26/21 01/26 10:45 01/26/21 10:45
General news	4-Week Bill Announcement to be released at 11:00 10:45 01/26/21 01/26 10:45 01/26/21 10:45
General news	4-Week Bill Announcement to be released at 11:00 10:45 01/26/21 01/26 10:45 01/26/21 10:45
General news	8-Week Bill Announcement to be released at 11:00 10:45 01/26/21 01/26 10:45 01/26/21 10:45
Conference/Events	Soligenix to hold a conference call » 10:44 01/26/21 01/26 10:44 01/26/21 10:44 SNGX Soligenix $1.74 / -0.1 (-5.43%) Management discusses U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SNGX Soligenix $1.74 / -0.1 (-5.43%) 01/07/21 Soligenix, Daavlin enter strategic partnership for lymphoma treatment device 12/28/20 Soligenix announces $1.5M NIH SBIR award for COVID-19 vaccine development 12/22/20 Soligenix announces DOM-INNATE trial did not meet primary endpoint 12/08/20 Soligenix shows extended protection with RiVax ricin toxin vaccine SNGX Soligenix $1.74 / -0.1 (-5.43%) 12/23/20 Alliance Global Partners Soligenix price target lowered to $5.75 from $7.25 at Alliance Global Partners 12/04/20 B. Riley Securities B. Riley sees 100% upside in Soligenix, starts with Buy rating 12/04/20 B. Riley Securities Soligenix initiated with a Buy at B. Riley Securities 07/28/20 Dawson James Soligenix downgraded to Neutral from Buy at Dawson James SNGX Soligenix $1.74 / -0.1 (-5.43%) 11/12/20 Soligenix reports Q3 EPS (6c), consensus (11c) 08/14/20 Soligenix reports Q2 EPS (10c), consensus (13c) SNGX Soligenix $1.74 / -0.1 (-5.43%) 08/14/20 Fly Intel: Pre-market Movers 14:30 Today Soligenix - SNGX

Hot Stocks	GameStop resumes trading after volatility halt, up 20% to $92.14 10:43 01/26/21 01/26 10:43 01/26/21 10:43 GME GameStop $81.70 / +4.89 (+6.37%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GME GameStop $81.70 / +4.89 (+6.37%) 09:47 Today GameStop rises 22.7% 09:45 Today GameStop trading resumes 09:40 Today GameStop trading halted, volatility trading pause 01/25/21 GameStop rises 60.3% GME GameStop $81.70 / +4.89 (+6.37%) 01/25/21 KeyBanc Bed Bath & Beyond activity being driven by Reddit message board, says KeyBanc 01/25/21 Fly Intel: Top five analyst downgrades 01/25/21 Telsey Advisory GameStop continues surge despite double downgrade at Telsey Advisory 01/25/21 Telsey Advisory GameStop downgraded to Underperform from Outperform at Telsey Advisory GME GameStop $81.70 / +4.89 (+6.37%) 12/08/20 GameStop reports Q3 adj. EPS (53c), consensus (85c) 12/08/20 GameStop reports Q3 EPS (29c), consensus (85c) 12/08/20 Notable companies reporting after market close 09/09/20 GameStop reports Q2 adj. EPS ($1.40), consensus ($1.13) GME GameStop $81.70 / +4.89 (+6.37%) 01/25/21 Hedgeye moves GameStop from best idea list to 'long bench,' Bloomberg says 01/22/21 Citron Research no longer commenting on GameStop 01/19/21 Citron sees five reasons GameStop will trade 'back to $20 fast' 01/16/21 GameStop stock double last week, challenges remain, Barron's says GME GameStop $81.70 / +4.89 (+6.37%) 01/25/21 Fly Intel: Wall Street's top stories for Monday 01/25/21 Fly Intel: Wall Street's top stories at midday 01/25/21 GameStop jumps above $100 in volatile trading despite double downgrade to sell 01/25/21 Walmart downgrade, Alibaba initiation among today's top calls on Wall Street GME GameStop $81.70 / +4.89 (+6.37%) 10:43 Today Chamath Palihapitiya bought February $115 calls on GameStop 08:55 Today Notable open interest changes for January 26th 07:30 Today Unusual put flow in option market yesterday 01/25/21 NYSE changes bid/ask differentials on options for GameStop, iRobot
Options	Chamath Palihapitiya bought February $115 calls on GameStop » 10:43 01/26/21 01/26 10:43 01/26/21 10:43 GME GameStop $81.70 / +4.89 (+6.37%) , IPOE Social Capital Hedosophia Holdings Corp. V $21.15 / +0.765 (+3.75%) Social Capital Chairman… Social Capital Chairman Chamath Palihapitiya disclosed on Twitter that he bought February $115 calls on GameStop this morning. He tweeted, "Lots of $GME talk soooooo.... We bought Feb $115 calls on $GME this morning. Let's gooooooo!!!!!!!!" Shares of GameStop halted for volatility after rising 16% to $89.31 in morning trading. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GME IPOE GME GameStop $81.70 / +4.89 (+6.37%) 09:47 Today GameStop rises 22.7% 09:45 Today GameStop trading resumes 09:40 Today GameStop trading halted, volatility trading pause 01/25/21 GameStop rises 60.3% IPOE Social Capital Hedosophia Holdings Corp. V $21.15 / +0.765 (+3.75%) 01/20/21 Social Capital Hedosophia Holdings Corp. V rises 7.5% 01/07/21 Social Capital Hedosophia V trading resumes 01/07/21 SoFi sees Social Capital V transaction to deliver up to $2.4B of gross proceeds 01/07/21 SoFi to become publicly-traded via merger with Social Capital Hedosophia V GME IPOE GME GameStop $81.70 / +4.89 (+6.37%) 01/25/21 KeyBanc Bed Bath & Beyond activity being driven by Reddit message board, says KeyBanc 01/25/21 Fly Intel: Top five analyst downgrades 01/25/21 Telsey Advisory GameStop continues surge despite double downgrade at Telsey Advisory 01/25/21 Telsey Advisory GameStop downgraded to Underperform from Outperform at Telsey Advisory IPOE Social Capital Hedosophia Holdings Corp. V $21.15 / +0.765 (+3.75%) GME GME GameStop $81.70 / +4.89 (+6.37%) 12/08/20 GameStop reports Q3 adj. EPS (53c), consensus (85c) 12/08/20 GameStop reports Q3 EPS (29c), consensus (85c) 12/08/20 Notable companies reporting after market close 09/09/20 GameStop reports Q2 adj. EPS ($1.40), consensus ($1.13) GME IPOE GME GameStop $81.70 / +4.89 (+6.37%) 01/25/21 Hedgeye moves GameStop from best idea list to 'long bench,' Bloomberg says 01/22/21 Citron Research no longer commenting on GameStop 01/19/21 Citron sees five reasons GameStop will trade 'back to $20 fast' 01/16/21 GameStop stock double last week, challenges remain, Barron's says IPOE Social Capital Hedosophia Holdings Corp. V $21.15 / +0.765 (+3.75%) 01/07/21 SoFi nears deal to go public with SPAC backed by Palihapitiya, Reuters says 01/07/21 Social Capital Hedosophia Holdings V near deal to take SoFi public, Reuters says GME IPOE GME GameStop $81.70 / +4.89 (+6.37%) 01/25/21 Fly Intel: Wall Street's top stories for Monday 01/25/21 Fly Intel: Wall Street's top stories at midday 01/25/21 GameStop jumps above $100 in volatile trading despite double downgrade to sell 01/25/21 Walmart downgrade, Alibaba initiation among today's top calls on Wall Street IPOE Social Capital Hedosophia Holdings Corp. V $21.15 / +0.765 (+3.75%) 01/10/21 Opening Day: Cullinan, Gracell surge in debut as SPAC craze continues 01/07/21 Fly Intel: Wall Street's top stories for Thursday 10/11/20 Opening Day: iHuman makes trading debut amid U.S.-China tensions GME IPOE GME GameStop $81.70 / +4.89 (+6.37%) 08:55 Today Notable open interest changes for January 26th 07:30 Today Unusual put flow in option market yesterday 01/25/21 NYSE changes bid/ask differentials on options for GameStop, iRobot 01/25/21 Notable open interest changes for January 25th IPOE Social Capital Hedosophia Holdings Corp. V $21.15 / +0.765 (+3.75%) 12/23/20 new option listings and one option delisting on December 23rd
Syndicate	Green Brick 6M share Secondary priced at $20.95 » 10:42 01/26/21 01/26 10:42 01/26/21 10:42 GRBK Green Brick $20.83 / -0.12 (-0.57%) Barclays and Goldman… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events GRBK Green Brick $20.83 / -0.12 (-0.57%) 01/22/21 Green Brick reports Q4 new homes delivered 585 01/05/21 Green Brick to add over 2,400 homes in TX community with total value of $640M 11/16/20 Einhorn's Greenlight buys Twitter, exits Whirlpool in Q3 10/27/20 Einhorn's Greenlight Capital takes new long positions in Synnex, NCR GRBK Green Brick $20.83 / -0.12 (-0.57%) 12/21/20 B. Riley Securities Green Brick price target raised to $28 from $24 at B. Riley Securities 11/25/20 BTIG Green Brick downgraded to Neutral from Buy at BTIG 11/25/20 BTIG Green Brick downgraded to Neutral from Buy at BTIG 11/18/20 JMP Securities Green Brick price target raised to $30 from $18 at JMP Securities GRBK Green Brick $20.83 / -0.12 (-0.57%) 01/22/21 Green Brick sees FY20 EPS $2.21-$2.23, consensus $2.29 10/29/20 Green Brick reports Q EPS 68c, consensus 43c 08/04/20 Green Brick reports Q2 EPS 67c, consensus 42c 26 Jan GRBK Green Brick $20.83 / -0.12 (-0.57%) 11/25/20 Fly Intel: After-Hours Movers 08/04/20 Fly Intel: After-Hours Movers 03/09/21 Green Brick - GRBK
On The Fly	Bed Bath & Beyond up again as UBS says sell, take profits after rally » 10:42 01/26/21 01/26 10:42 01/26/21 10:42 BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) , BB BlackBerry $18.48 / +0.44 (+2.44%) , FB Facebook $281.99 / +3.98 (+1.43%) Shares of Bed Bath &… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BBBY BB FB BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) 01/19/21 Bed Bath & Beyond completes sale of Cost Plus World Market to Kingswood 01/07/21 Bed Bath & Beyond drops 11% to $18.61 after Q3 results, guidance miss estimates 01/07/21 Bed Bath & Beyond: Guidance assumes flat comparable sales in FY21 01/07/21 Bed Bath & Beyond: Digital comp sales up 94% in Q3, store comp sales down 14% BB BlackBerry $18.48 / +0.44 (+2.44%) 05:45 Today BlackBerry, Baidu expand partnership for autonomous driving technology 01/25/21 BlackBerry rises 34.4% 01/25/21 BlackBerry 'not aware' of any material, undisclosed corporate developments 01/25/21 BlackBerry rises 39.8% FB Facebook $281.99 / +3.98 (+1.43%) 01/21/21 Facebook: Trump's access to remain suspended 'indefinitely' 01/21/21 Facebook referrering former President Trump's suspension to Oversight Board 01/11/21 Facebook to remove content containing phrase 'stop the steal' 01/11/21 Airbnb says its PAC will 'withhold support' from those who opposed certification BBBY BB FB BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) 09:53 Today Fly Intel: Top five analyst downgrades 07:47 Today Bed Bath & Beyond downgraded to Sell at UBS after recent run-up in stock 07:19 Today Raymond James Bed Bath & Beyond downgraded to Market Perform from Strong Buy at Raymond James 06:43 Today UBS Bed Bath & Beyond downgraded to Sell from Neutral at UBS BB BlackBerry $18.48 / +0.44 (+2.44%) 09:53 Today Fly Intel: Top five analyst downgrades 05:11 Today RBC Capital BlackBerry downgraded to Underperform from Sector Perform at RBC Capital 12/18/20 TD Securities BlackBerry price target raised to $8.50 from $5.50 at TD Securities 12/15/20 RBC Capital BlackBerry price target raised to $7.50 from $5 at RBC Capital FB Facebook $281.99 / +3.98 (+1.43%) 08:31 Today Morgan Stanley Morgan Stanley work finds 'modestly rising' U.S. use of IG Shopping and Reels 07:02 Today Deutsche Bank Deutsche ups Facebook target to $350, sees upcoming Q4 as 'clearing event' 04:53 Today Piper Sandler Facebook Q4 results Wednesday should be 'strong,' says Piper Sandler 01/25/21 Morgan Stanley Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value BBBY BB FB BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) 01/07/21 Bed Bath & Beyond sees FY21 revenue $8B-$8.2B, consensus $9.61B 01/07/21 Bed Bath & Beyond sees Q4 revenue down double-digit percent, consensus $2.92B 01/07/21 Bed Bath & Beyond reports Q3 adjusted EPS 8c, consensus 19c 01/06/21 Notable companies reporting before tomorrow's open BB BlackBerry $18.48 / +0.44 (+2.44%) 12/17/20 BlackBerry reports Q3 adjusted EPS 2c, consensus (1c) 09/24/20 BlackBerry reports Q2 non-GAAP EPS 11c, consensus 2c FB Facebook $281.99 / +3.98 (+1.43%) 10/29/20 Facebook sees Q4 ad revenue growth rate higher than Q3 10/29/20 Facebook reports Q3 EPS $2.71, consensus $1.91 10/29/20 Notable companies reporting after market close 07/30/20 Facebook reports Q2 EPS $1.80, consensus $1.39 BBBY BB FB BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) 10/08/20 Legion's Kiper pitches OneSpan, Bed Bath as long ideas, Bloomberg reports BB BlackBerry $18.48 / +0.44 (+2.44%) 01/15/21 BlackBerry reports settlement with Facebook over patents, Bloomberg says FB Facebook $281.99 / +3.98 (+1.43%) 01/23/21 Big tech stocks are back, Barron's says 01/22/21 Facebook memo told employees to prioritize privacy, OneZero reports 01/21/21 Apple's first headset to focus on virtual reality, Bloomberg reports 01/20/21 Facebook rival MeWe adds 2.5M privacy-seeking users in a week, USA Today says BBBY BB FB BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) 10:05 Today Comcast upgrade, Bed Bath & Beyond downgrade among top calls on Wall Street 01/25/21 Fly Intel: Wall Street's top stories for Monday 01/25/21 Fly Intel: Wall Street's top stories at midday 01/07/21 Fly Intel: Wall Street's top stories for Thursday BB BlackBerry $18.48 / +0.44 (+2.44%) 01/25/21 Fly Intel: Wall Street's top stories at midday 01/20/21 #SocialStocks: Facebook could be in focus under new administration 12/17/20 Fly Intel: After-Hours Movers 12/01/20 Fly Intel: Wall Street's top stories for Tuesday FB Facebook $281.99 / +3.98 (+1.43%) 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/19/21 Fly Insider: REV Group, Neurocrine Bio among week's notable insider trades 01/19/21 Facebook upgrade, Roku initiation among today's top calls on Wall Street 01/27/21 Facebook - FB BBBY BB FB BBBY Bed Bath & Beyond $30.76 / +0.1 (+0.33%) 01/25/21 Bed Bath & Beyond call volume above normal and directionally bullish 01/25/21 Early notable gainers among liquid option names on January 25th 01/22/21 Bed Bath & Beyond call volume above normal and directionally bullish 01/22/21 Unusually active option classes on open January 22nd BB BlackBerry $18.48 / +0.44 (+2.44%) 01/20/21 Notable open interest changes for January 20th 01/15/21 Unusual call flow in option market yesterday 01/14/21 BlackBerry call volume above normal and directionally bullish 01/11/21 Unusually active option classes on open January 11th FB Facebook $281.99 / +3.98 (+1.43%) 01/15/21 Facebook call volume above normal and directionally bullish 12/21/20 Facebook call buyer realizes 33% same-day gains 12/10/20 Unusually active option classes on open December 10th 12/07/20 Facebook call volume above normal and directionally bullish
Hot Stocks	Twitter acquires newsletter company Revue » 10:39 01/26/21 01/26 10:39 01/26/21 10:39 TWTR Twitter $50.56 / +2.71 (+5.66%) In a company blog post,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TWTR Twitter $50.56 / +2.71 (+5.66%) 01/25/21 Twitter announces proposed settlement of shareholder derivative lawsuits 01/25/21 Twitter introduces Birdwatch community-based approach to misinformation 01/13/21 Twitter CEO says @realDonaldTrump ban 'right decision' for company 01/11/21 Twitter suspends over 70,000 accounts since Friday TWTR Twitter $50.56 / +2.71 (+5.66%) 01/20/21 Piper Sandler Twitter initiated with a Neutral at Piper Sandler 01/19/21 KeyBanc Facebook price target raised to $345 from $340 at KeyBanc 01/13/21 Fly Intel: Top five analyst upgrades 01/13/21 MKM Partners Twitter upgraded to Buy from Neutral at MKM Partners TWTR Twitter $50.56 / +2.71 (+5.66%) 10/29/20 Twitter reports Q3 adjusted EPS 19c, consensus 6c 10/29/20 Notable companies reporting after market close TWTR Twitter $50.56 / +2.71 (+5.66%) 06:06 Today Twitter bans MyPillow CEO on 'repeated violations' of policy, NY Times reports 01/21/21 China state media seeing less 'likes,' or 'retweets,' on Twitter, Newsweek says 01/20/21 Facebook rival MeWe adds 2.5M privacy-seeking users in a week, USA Today says 01/10/21 Airbnb Section 230 use underscores law's reach beyond Facebook, WSJ says TWTR Twitter $50.56 / +2.71 (+5.66%) 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler 01/13/21 Tesla initiation, Home Depot upgrade among today's top calls on Wall Street 02/11/21 Technology & Internet Virtual Conference 02/09/21 Twitter - TWTR 02/25/21 Twitter, Inc. TWTR Twitter $50.56 / +2.71 (+5.66%) 01/20/21 Unusually active option classes on open January 20th 01/12/21 Notable open interest changes for January 12th 12/14/20 Twitter call volume above normal and directionally bullish 12/11/20 Notable open interest changes for December 11th

Hot Stocks	Eli Lilly: Etesevimab, bamlanivimab reduced risk of Covid hospitalizations » 10:38 01/26/21 01/26 10:38 01/26/21 10:38 LLY Eli Lilly $211.92 / -0.58 (-0.27%) , AMGN Amgen $255.50 / -1.24 (-0.48%) Junshi Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY AMGN LLY Eli Lilly $211.92 / -0.58 (-0.27%) 07:24 Today AbCellera announces results from BLAZE-1 trial with Eli Lilly 06:54 Today Eli Lilly announces BLAZE-1 trial meets primary endpoint 01/22/21 Eli Lilly completes acquisition of Prevail Therapeutics 01/21/21 AbCellera-discovered antibody prevented COVID-19 in nursing homes, reduced risks AMGN Amgen $255.50 / -1.24 (-0.48%) 01/21/21 Amgen granted FDA Orphan Drug Designation for carfilzomib 01/11/21 Amgen aims to achieve carbon neutrality by 2027 01/07/21 Moderna announces Corinne Le Goff as chief commercial officer 12/28/20 BeiGene announces three oncology medicines included in NDRL by China NHSA LLY AMGN LLY Eli Lilly $211.92 / -0.58 (-0.27%) 01/20/21 Citi Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data 01/19/21 Roth Capital Merus price target raised to $32 from $19 at Roth Capital 01/19/21 Fly Intel: Top five analyst upgrades 01/19/21 Mizuho Eli Lilly upgraded to Buy from Neutral at Mizuho AMGN Amgen $255.50 / -1.24 (-0.48%) 12/29/20 Daiwa Amgen initiated with a Buy at Daiwa 12/28/20 Oppenheimer Amgen price target lowered to $266 from $274 at Oppenheimer 12/15/20 Goldman Sachs Amgen downgraded to Buy from Conviction Buy at Goldman Sachs 12/09/20 SVB Leerink Amgen price target raised to $253 from $243 at SVB Leerink LLY AMGN LLY Eli Lilly $211.92 / -0.58 (-0.27%) 12/15/20 Eli Lilly sees FY21 EPS $7.75-$8.40, consensus $8.07 12/15/20 Eli Lilly raises FY20 EPS view to $7.45-$7.65 from $7.20-$7.40, consensus $7.32 12/02/20 Eli Lilly says updated purchase of LY-CoV555 to boost FY20 EPS view by 25c 10/27/20 Eli Lilly backs FY20 adj. EPS view $7.20-$7.40, consensus $7.28 AMGN Amgen $255.50 / -1.24 (-0.48%) 10/28/20 Amgen raises FY20 adjusted EPS view to $15.80-$16.15 from $15.10-$15.75 10/28/20 Amgen reports Q3 adjusted EPS $4.37, consensus $3.80 10/28/20 Notable companies reporting after market close 07/28/20 Amgen raises FY20 adjusted EPS view to $15.10-$15.75 from $14.85-$15.60 LLY AMGN LLY Eli Lilly $211.92 / -0.58 (-0.27%) 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports AMGN Amgen $255.50 / -1.24 (-0.48%) 08/24/20 Salesforce, Amgen, Honeywell to join DJIA index, Bloomberg reports LLY AMGN LLY Eli Lilly $211.92 / -0.58 (-0.27%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday AMGN Amgen $255.50 / -1.24 (-0.48%) 12/16/20 Fly Intel: After-Hours Movers 10/09/20 Fly Intel: Wall Street's top stories for Friday 10/09/20 Fly Intel: Wall Street's top stories at midday 10/09/20 GE reinstatement at Goldman among today's top calls on Wall Street 00:00 Today Pharmacovigilance & Risk Management Strategies Virtual Conference 01/28/21 IASLC Virtual World Conference on Lung Cancer 03/01/21 41st Annual Healthcare Virtual Conference 01/29/21 Eli Lilly - LLY 02/02/21 Amgen - AMGN LLY AMGN LLY Eli Lilly $211.92 / -0.58 (-0.27%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th AMGN Amgen $255.50 / -1.24 (-0.48%) 12/29/20 Early notable gainers among liquid option names on December 29th 08/25/20 Early notable gainers among liquid option names on August 25th 08/25/20 Unusually active option classes on open August 25th
Recommendations	Amarin in 'strong position' against Health Net, says Piper Sandler » 10:35 01/26/21 01/26 10:35 01/26/21 10:35 AMRN Amarin $7.38 / -0.17 (-2.25%) , GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) , TEVA Teva $12.33 / -0.065 (-0.52%) Amarin (AMRN) yesterday… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMRN GSK TEVA AMRN Amarin $7.38 / -0.17 (-2.25%) 10:32 Today Amarin expands Vascepa patent infringement suit to include Health Net 01/21/21 Amarin announces CSC included icosapent ethyl in CD prevention guidelines 01/07/21 Amarin provides outlook on 2021 cash & expenses 12/14/20 Amarin says Vascepa reduced Covid inflammation by 25% in early study GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) 01/21/21 Immutep announces GlaxoSmithKline discontinuation of GSK2831781 trial 01/21/21 ViiV Healthcare announces FDA approval of Cabenuva 01/21/21 BiondVax names Amir Reichman as new CEO 01/12/21 Vir Biotechnology, GlaxoSmithKline to evaluate VIR-7832 in COVID-19 patients TEVA Teva $12.33 / -0.065 (-0.52%) 01/15/21 Teva ANDA for Bexarotene approved by FDA 01/14/21 Teva announces availability of generic version of NuvaRing 01/07/21 Teva, MedinCell present results for study on efficacy of schizophrenia treatment 11/27/20 Teva receives tentative approval from FDA for micafungin sodium AMRN GSK TEVA AMRN Amarin $7.38 / -0.17 (-2.25%) 01/25/21 Cantor Fitzgerald Cantor says Amarin opportunity for Vascepa outside U.S. still 'underappreciated' 01/25/21 Piper Sandler Piper Sandler reiterates 'conviction call' on Amarin into European decision 01/22/21 Cowen Amarin remains undervalued under almost any scenario, says Cowen 01/08/21 Piper Sandler Piper sees 're-birth' for Amarin shares in 2021, keeps $19 price target GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) 01/20/21 UBS GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS 01/20/21 Fly Intel: Top five analyst downgrades 01/20/21 Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse 01/20/21 Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse TEVA Teva $12.33 / -0.065 (-0.52%) 12/21/20 Gabelli Teva named 'Best Idea for 2021' at Gabelli 11/27/20 H.C. Wainwright Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright 11/24/20 Oppenheimer Teva initiated with a Perform at Oppenheimer 11/23/20 Citi Citi recommends pair trade of overweight Endo, underweight Teva AMRN GSK TEVA AMRN Amarin $7.38 / -0.17 (-2.25%) 01/07/21 Amarin sees FY20 revenue up 42% to $610M, consensus $619.19M 11/05/20 Amarin reports Q3 non-GAAP EPS (1c), consensus 1c 08/04/20 Amarin reports Q2 adjusted EPS 4c, consensus (7c) GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% 07/29/20 GlaxoSmithKline reports Q2 adjusted EPS 19.2p, down 37% AER TEVA Teva $12.33 / -0.065 (-0.52%) 11/05/20 Teva sees FY20 EPS $2.40-$2.55, consensus $2.51 11/05/20 Teva reports Q3 EPS 58c, consensus 58c 08/05/20 Teva reports Q2 EPS 55c, consensus 53c 08/04/20 Notable companies reporting before tomorrow's open AMRN GSK TEVA AMRN Amarin $7.38 / -0.17 (-2.25%) 11/04/20 Amarin loses bid for rehearing of Vascepa case, Bloomberg says GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says TEVA Teva $12.33 / -0.065 (-0.52%) 11/13/20 Teva facing EU antitrust investigation over Copaxone sales, Bloomberg reports 10/21/20 Purdue Pharma to plead guilty in $8B-plus deal, AP reports 10/02/20 GlaxoSmithKline verdict of $235M against Teva revived on appeal, Bloomberg says 08/25/20 Teva alleged to have overcharged U.S. consumers at least $350M, Bloomberg says AMRN GSK TEVA AMRN Amarin $7.38 / -0.17 (-2.25%) 01/21/21 Fly Intel: After-Hours Movers 12/14/20 Amarin rises following 'encouraging' results in COVID patients 10/26/20 Fly Intel: Pre-market Movers 10/15/20 Fly Intel: After-Hours Movers GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 12/11/20 Fly Intel: Wall Street's top stories for Friday 12/11/20 Fly Intel: Wall Street's top stories at midday TEVA Teva $12.33 / -0.065 (-0.52%) 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Fly Intel: Wall Street's top stories at midday 11/18/20 Fly Intel: After-Hours Movers 08/26/20 Fly Intel: Pre-market Movers 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/03/21 GlaxoSmithKline - GSK 02/10/21 Teva - TEVA AMRN GSK TEVA AMRN Amarin $7.38 / -0.17 (-2.25%) 01/08/21 Amarin call volume above normal and directionally bullish 01/04/21 Amarin call volume above normal and directionally bullish 12/17/20 Amarin call volume above normal and directionally bullish 12/14/20 Unusually active option classes on open December 14th GSK GlaxoSmithKline $39.12 / +0.21 (+0.54%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish 08/03/20 Unusually active option classes on open August 3rd 07/31/20 Unusually active option classes on open July 31st TEVA Teva $12.33 / -0.065 (-0.52%) 01/19/21 Teva call volume above normal and directionally bullish 01/06/21 Notable open interest changes for January 6th 01/04/21 Teva call volume above normal and directionally bullish 12/23/20 Teva put volume heavy and directionally bearish
Options	Weight Watchers put volume heavy and directionally bearish » 10:35 01/26/21 01/26 10:35 01/26/21 10:35 WW WW $25.00 / +0.04 (+0.16%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals WW WW $25.00 / +0.04 (+0.16%) 01/05/21 The Vitamin Shoppe, WW announce strategic partnership 11/16/20 WW launches new myWW+ with enhancements to app 10/14/20 Zoom Video launches OnZoom a 'marketplace for immersive experiences' 10/14/20 WW collaborates with Zoom Video for launch of OnZoom, Zapps WW WW $25.00 / +0.04 (+0.16%) 12/15/20 Wolfe Research WW initiated with an Outperform at Wolfe Research 12/09/20 DA Davidson WW price target raised to $38 from $33 at DA Davidson 10/09/20 B. Riley Securities Medifast price target raised to $230 from $220 at B. Riley Securities 09/25/20 Citi WW price target lowered to $32 from $35 at Citi WW WW $25.00 / +0.04 (+0.16%) 10/29/20 WW reports Q3 end of period subscribers up 5% year-over-year 10/29/20 WW reports Q3 EPS 78c, consensus 63c 10/29/20 Notable companies reporting after market close 08/04/20 WW reports Q2 EPS 67c, consensus 70c WW WW $25.00 / +0.04 (+0.16%) 08/27/20 Amazon partners with WW for Halo fitness wristband, CNBC reports
General news	Treasury Action: yields are little changed to slightly cheaper » 10:35 01/26/21 01/26 10:35 01/26/21 10:35 Treasury Action: yields… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Freeport McMoRan: Copper sales on track to grow 20% in 2021 vs. 2020 10:34 01/26/21 01/26 10:34 01/26/21 10:34 FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 10:34 Today Freeport McMoRan: Gold sales on track to grow 50% in 2021 vs. 2020 10:26 Today Freeport: Fundamental outlook for copper better than 10 years ago 10:26 Today Freeport: Talking with third party to build Greenfield smelter at alt. location 10:25 Today Freeport McMoRan: Not required to do deals FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 01/20/21 B. Riley Securities Freeport McMoRan price target raised to $32 from $30 at B. Riley Securities 01/13/21 Deutsche Bank Freeport McMoRan price target raised to $33 from $20 at Deutsche Bank 01/05/21 Fly Intel: Top five analyst upgrades 01/05/21 B. Riley Securities Freeport McMoRan price target raised to $30 from $26 at B. Riley Securities FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 08:12 Today Freeport McMoRan reports Q4 adjusted EPS 39c, consensus 38c 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/22/20 Freeport McMoRan reports Q3 EPS 22c, consensus 21c FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 09/16/20 CFO says Freeport not wanting to be 'distracted' by buyout bids, Reuters reports 08/24/20 Workers bar access to Freeport Indonesia's Grasberg mine, Reuters reports FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 11/11/20 Fly Intel: After-Hours Movers 10:00 Today Freeport McMoRan - FCX FCX Freeport McMoRan $27.64 / -1.35 (-4.66%) 01/25/21 Freeport McMoRan call volume above normal and directionally bullish 01/07/21 Early notable gainers among liquid option names on January 7th 01/04/21 Early notable gainers among liquid option names on January 4th 12/31/20 Unusually active option classes on open December 31st

Events

Earnings calls, analyst events, roadshows and more

Today at 11:00

8-Week Bill Announcement Government Event
Today at 11:00

4-Week Bill Announcement Government Event
FFWM
Today at 11:00

First Foundation - FFWM Conference Calls
EFSC
Today at 11:00

Enterprise Financial - EFSC Conference Calls
ELS
Today at 11:00

Equity Lifestyle - ELS Conference Calls
PEBO
Today at 11:00

Peoples Bancorp - PEBO Conference Calls
LMT
Today at 11:00

Lockheed Martin - LMT Conference Calls
BXS
Today at 11:00

BancorpSouth - BXS Conference Calls
CVLG
Today at 11:00

Covenant Logistics - CVLG Conference Calls
GGG
Today at 11:00

Graco - GGG Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares CRKN X CRKN Crown Electrokinetics Secondary Managers: Roth Capital, National Securities, Colliers Priced at: $4.50 4.15M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James Priced at: $1.75 14.3M Shares SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG Priced at: $2.05 15.244M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GRBK X GRBK Green Brick Secondary Managers: Barclays & Goldman Sachs Priced at: $20.95 6M Shares
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer $22.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $27.00-29.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA $23.69 12M Shares CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., $104.50 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen $81.35 3.5M Shares SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares
Fri	No deals

View All Syndicate Announcements »

Aramark says 'activating strategies to accelerate future revenue growth'

TODAY'S FREE FLY STORIES

Get Full Fly Access